Stock Scorer
Stock Board CompareNew Screen
Donate
…
Report Measures Companies
Sign in

The highest revenue growth per diluted share, trailing twelve months against the prior twelve

Revenue growth per diluted share, trailing twelve months against the prior twelve

Ranked from the filings of the companies this site has read, under Growth. 50 of them report a figure for this; the rest are absent rather than ranked last, because a filing that does not carry a number is not a company that scores badly on it.

#CompanySales/sh Y/Y
1 Vir Biotechnology, Inc. VIR 1,469.72%
2 Century Therapeutics, Inc. IPSC 1,405.08%
3 AST SPACEMOBILE, INC. ASTS 1,322.04%
4 ARBUTUS BIOPHARMA CORP ABUS 1,041.89%
5 Gubra A/S GUBRA.CO 900.02%
6 Nuvation Bio Inc. NUVB 831.24%
7 MeiraGTx Holdings plc MGTX 809.99%
8 Protagonist Therapeutics, Inc PTGX 715.64%
9 Brilliant Earth Group, Inc. BRLT 610.33%
10 NEBIUS GROUP N.V. NBIS 556.98%
11 Cango Inc. CANG 529.46%
12 Hiab Oyj HIAB.HE 502.40%
13 AQUA BIO TECHNOLOGY ASA ABTEC.OL 478.93%
14 EOS ENERGY ENTERPRISES, INC. EOSE 415.22%
15 QXO, INC. QXO 408.30%
16 UBM Development AG UBS.VI 392.04%
17 INTEGRA RESOURCES CORP. ITRG 357.72%
18 T1 Energy Inc. TE 326.46%
19 PHILOGEN S.P.A. PHIL.MI 324.79%
20 ENERGY VAULT HOLDINGS, INC. NRGV 307.66%
21 GALAPAGOS NV LKFT 303.50%
22 American Bitcoin Corp. ABTC 282.99%
23 AUTOLUS THERAPEUTICS PLC AUTL 275.98%
24 IONQ, INC. IONQ 257.56%
25 Blackstone Mortgage Trust, Inc. BXMT 247.55%
26 Ondas Inc. ONDS 240.00%
27 DigitalBridge Group, Inc. DBRG 229.32%
28 HOOKER FURNISHINGS CORPORATION HOFT 223.51%
29 Syndax Pharmaceuticals, Inc. SNDX 218.91%
30 PEDEVCO CORP. PED 218.42%
31 EXMAR EXM.BR 211.12%
32 CREDO TECHNOLOGY GROUP HOLDING LTD CRDO 194.15%
33 BridgeBio Pharma, Inc. BBIO 193.78%
34 GREENCOAT UK WIND PLC UKW.L 172.52%
35 AEVEX Corp. AVEX 171.05%
36 CPI FIM SA ORCL.LU 167.33%
37 Micron Technology, Inc. MU 165.31%
38 Vaxart, Inc. VXRT 164.21%
39 Resolute Holdings Management, Inc. RHLD 159.55%
40 Sandisk Corporation SNDK 157.80%
41 TOYO Co., Ltd TOYO 144.84%
42 Cadeler A/S CDLR 143.96%
43 Uxin Ltd UXIN 143.32%
44 WESTERN ALLIANCE BANCORPORATION WAL 140.85%
45 CADELER A/S CADLR.OL 140.82%
46 Republic Airways Holdings Inc. RJET 136.88%
47 MADRIGAL PHARMACEUTICALS, INC. MDGL 136.14%
48 AT & S Austria Technologie & Systemtechnik Aktiengesellschaft ATS.VI 135.76%
49 INSMED INC INSM 135.52%
50 ACG METALS LIMITED ACG.L 134.80%

How this measure is worked out

Revenue per diluted share, trailing twelve months against the prior twelve

Diluted shares counts every share that could come to exist, including options and convertibles. Measuring per share means growth paid for by issuing shares does not count as growth in an owner's claim on the business.

0% earns a 1, 80% a 10, logarithmically

More about Sales/sh Y/Y, and the XBRL tags behind it

What this ranking is not

It is not advice, and a high place is not a recommendation. A company can lead on one measure and fail on every other; that is the reason this site scores five dimensions rather than one and lets you weigh them yourself.

It also ranks only what has been read. A company whose filings are not in this database cannot appear here however well it would have done, and a company whose filing does not tag this figure is absent rather than last.

Worked out on 2026-09-27.

Every other measure ranked · All 64 measures explained